questionsmedicales.fr
Organisations et économie des soins de santé
Organismes
Agences internationales
Agences internationales : Questions médicales fréquentes
Diagnostic
5
Épidémiologie
Surveillance épidémiologique
Tests diagnostiques
Méthodes de diagnostic
Organisation mondiale de la santé
Normes de diagnostic
Collecte de données
Rapports de santé
Symptômes
5
Symptômes
Surveillance des maladies
Classification des symptômes
Évaluation clinique
Listes de symptômes
Identification des maladies
Interventions de santé
Planification des ressources
Variabilité des symptômes
Souches de maladies
Prévention
5
Stratégies de prévention
Contrôle des infections
Vaccination
Campagnes de sensibilisation
Collaboration internationale
Politiques de santé publique
Financement de la santé
Dons pour la santé
Adaptation culturelle
Programmes de santé
Traitements
5
Traitements médicaux
Protocoles de traitement
Essais cliniques
Évaluation des traitements
Recherche médicale
Financement de la recherche
Distribution des médicaments
Systèmes de santé
Variabilité des traitements
Réglementations sanitaires
Complications
5
Complications médicales
Effets secondaires
Pharmacovigilance
Rapports cliniques
Lignes directrices cliniques
Gestion des complications
Ajustements de traitement
Soins supplémentaires
Variabilité des complications
Comorbidités
Facteurs de risque
5
Facteurs de risque
Antécédents médicaux
Évaluation des risques
Analyses de données
Maladies infectieuses
Facteurs de risque spécifiques
Communication de la santé
Sensibilisation du public
Modification des comportements
Prévention des maladies
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Agences internationales : Questions médicales les plus fréquentes",
"headline": "Agences internationales : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Agences internationales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-02",
"dateModified": "2026-03-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Agences internationales"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Organismes",
"url": "https://questionsmedicales.fr/mesh/D009938",
"about": {
"@type": "MedicalCondition",
"name": "Organismes",
"code": {
"@type": "MedicalCode",
"code": "D009938",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Organisation de coopération et de développement économiques",
"alternateName": "Organisation for Economic Co-Operation and Development",
"url": "https://questionsmedicales.fr/mesh/D066150",
"about": {
"@type": "MedicalCondition",
"name": "Organisation de coopération et de développement économiques",
"code": {
"@type": "MedicalCode",
"code": "D066150",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.514.481"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nations Unies",
"alternateName": "United Nations",
"url": "https://questionsmedicales.fr/mesh/D014480",
"about": {
"@type": "MedicalCondition",
"name": "Nations Unies",
"code": {
"@type": "MedicalCode",
"code": "D014480",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.514.718"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Unesco",
"alternateName": "UNESCO",
"url": "https://questionsmedicales.fr/mesh/D000076892",
"about": {
"@type": "MedicalCondition",
"name": "Unesco",
"code": {
"@type": "MedicalCode",
"code": "D000076892",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.514.718.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Organisation mondiale de la santé",
"alternateName": "World Health Organization",
"url": "https://questionsmedicales.fr/mesh/D014944",
"about": {
"@type": "MedicalCondition",
"name": "Organisation mondiale de la santé",
"code": {
"@type": "MedicalCode",
"code": "D014944",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.514.718.800"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Organisation panaméricaine de la santé",
"alternateName": "Pan American Health Organization",
"url": "https://questionsmedicales.fr/mesh/D010175",
"about": {
"@type": "MedicalCondition",
"name": "Organisation panaméricaine de la santé",
"code": {
"@type": "MedicalCode",
"code": "D010175",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.514.718.800.628"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Organisation panaméricaine de la santé",
"alternateName": "Pan American Health Organization",
"url": "https://questionsmedicales.fr/mesh/D010175",
"about": {
"@type": "MedicalCondition",
"name": "Organisation panaméricaine de la santé",
"code": {
"@type": "MedicalCode",
"code": "D010175",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.514.718.800.628"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Agences internationales",
"alternateName": "International Agencies",
"code": {
"@type": "MedicalCode",
"code": "D007390",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "May Abdel-Wahab",
"url": "https://questionsmedicales.fr/author/May%20Abdel-Wahab",
"affiliation": {
"@type": "Organization",
"name": "Division of Human Health (NAHU), International Atomic Energy Agency (IAEA) Vienna, Austria."
}
},
{
"@type": "Person",
"name": "Yaroslav Pynda",
"url": "https://questionsmedicales.fr/author/Yaroslav%20Pynda",
"affiliation": {
"@type": "Organization",
"name": "Division of Human Health, International Atomic Energy Agency, Vienna, Austria."
}
},
{
"@type": "Person",
"name": "Wen Wen",
"url": "https://questionsmedicales.fr/author/Wen%20Wen",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, Rikkyo University, 1-2-26 Kitano, Niiza, Saitama 352-8558, Japan; Department of Precision Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan. Electronic address: wen@rikkyo.ac.jp."
}
},
{
"@type": "Person",
"name": "Virginia Tsapaki",
"url": "https://questionsmedicales.fr/author/Virginia%20Tsapaki",
"affiliation": {
"@type": "Organization",
"name": "Dosimetry and Medical Radiation Physics Section, International Atomic Energy Agency, Vienna, Austria."
}
},
{
"@type": "Person",
"name": "Maria Rentetzi",
"url": "https://questionsmedicales.fr/author/Maria%20Rentetzi",
"affiliation": {
"@type": "Organization",
"name": "Chair for Science, Technology and Gender Studies, Friedrich-Alexander University Erlangen-Nuremberg, Bismarckstrasse 6, Erlangen 91054, Germany. Electronic address: maria.rentetzi@fau.de."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Development and the social sciences: international agencies in Brazilian favelas in the 1960s.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37194751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/S0104-59702023000100015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of Occupational Carcinogenic Risk by Comparing Data from the Italian Register of Occupational Exposures to Carcinogens (SIREP) with the International Agency for Research on Cancer (IARC) Evidence.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37239576",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20105850"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Novel Framework for Internal Responses to Detection of Pathogens in Wastewater by Public Health Agencies.",
"datePublished": "2024-06-13",
"url": "https://questionsmedicales.fr/article/38868902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00333549241253787"
}
},
{
"@type": "ScholarlyArticle",
"name": "Technical specifications of dose management systems: An international atomic energy agency survey.",
"datePublished": "2023-12-07",
"url": "https://questionsmedicales.fr/article/38060709",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acm2.14219"
}
},
{
"@type": "ScholarlyArticle",
"name": "HTA model for laboratory medicine technologies: overview of approaches adopted in some international agencies.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39044459",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/cclm-2023-1203"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organismes",
"item": "https://questionsmedicales.fr/mesh/D009938"
},
{
"@type": "ListItem",
"position": 4,
"name": "Agences internationales",
"item": "https://questionsmedicales.fr/mesh/D007390"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Agences internationales - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Agences internationales",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Agences internationales",
"description": "Comment les agences internationales évaluent-elles les épidémies ?\nQuelles méthodes de diagnostic sont recommandées ?\nComment les agences définissent-elles une pandémie ?\nQuel rôle joue l'OMS dans le diagnostic des maladies ?\nComment les données sont-elles collectées pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007390#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Agences internationales",
"description": "Quels symptômes les agences surveillent-elles lors d'épidémies ?\nComment les symptômes sont-ils classifiés ?\nLes agences publient-elles des listes de symptômes ?\nComment les symptômes influencent-ils les interventions ?\nLes symptômes varient-ils selon les régions ?",
"url": "https://questionsmedicales.fr/mesh/D007390#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Agences internationales",
"description": "Quelles stratégies de prévention sont mises en place ?\nComment les agences promeuvent-elles la vaccination ?\nLes agences collaborent-elles avec des gouvernements ?\nComment la prévention est-elle financée ?\nLes programmes de prévention sont-ils adaptés aux cultures ?",
"url": "https://questionsmedicales.fr/mesh/D007390#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Agences internationales",
"description": "Quels traitements les agences recommandent-elles ?\nComment les traitements sont-ils évalués ?\nLes agences soutiennent-elles la recherche sur les traitements ?\nComment les traitements sont-ils distribués ?\nLes traitements varient-ils selon les pays ?",
"url": "https://questionsmedicales.fr/mesh/D007390#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Agences internationales",
"description": "Quelles complications sont surveillées par les agences ?\nComment les complications sont-elles signalées ?\nLes agences fournissent-elles des lignes directrices sur les complications ?\nComment les complications influencent-elles les traitements ?\nLes complications varient-elles selon les populations ?",
"url": "https://questionsmedicales.fr/mesh/D007390#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Agences internationales",
"description": "Quels facteurs de risque sont identifiés par les agences ?\nComment les agences évaluent-elles les facteurs de risque ?\nLes facteurs de risque sont-ils différents selon les maladies ?\nComment les agences communiquent-elles sur les facteurs de risque ?\nLes facteurs de risque peuvent-ils être modifiés ?",
"url": "https://questionsmedicales.fr/mesh/D007390#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les agences internationales évaluent-elles les épidémies ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles utilisent des données épidémiologiques et des modèles de propagation."
}
},
{
"@type": "Question",
"name": "Quelles méthodes de diagnostic sont recommandées ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR, sérologiques et les enquêtes de santé sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Comment les agences définissent-elles une pandémie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une pandémie est une épidémie qui se propage sur plusieurs continents."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'OMS dans le diagnostic des maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'OMS fournit des directives et des normes pour le diagnostic des maladies."
}
},
{
"@type": "Question",
"name": "Comment les données sont-elles collectées pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les données proviennent de rapports de santé, d'hôpitaux et de laboratoires."
}
},
{
"@type": "Question",
"name": "Quels symptômes les agences surveillent-elles lors d'épidémies ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon la maladie, mais incluent fièvre, toux, fatigue."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils classifiés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont classifiés par gravité et fréquence dans les populations affectées."
}
},
{
"@type": "Question",
"name": "Les agences publient-elles des listes de symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles publient des listes pour aider à l'identification précoce des maladies."
}
},
{
"@type": "Question",
"name": "Comment les symptômes influencent-ils les interventions ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes guident les priorités d'intervention et les ressources nécessaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les régions ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction des souches et des populations."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont mises en place ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les stratégies incluent la vaccination, l'éducation et le contrôle des infections."
}
},
{
"@type": "Question",
"name": "Comment les agences promeuvent-elles la vaccination ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles organisent des campagnes de sensibilisation et fournissent des vaccins."
}
},
{
"@type": "Question",
"name": "Les agences collaborent-elles avec des gouvernements ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles collaborent pour développer des politiques de santé publique efficaces."
}
},
{
"@type": "Question",
"name": "Comment la prévention est-elle financée ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le financement provient de dons, de gouvernements et d'organisations privées."
}
},
{
"@type": "Question",
"name": "Les programmes de prévention sont-ils adaptés aux cultures ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les programmes sont adaptés pour respecter les contextes culturels locaux."
}
},
{
"@type": "Question",
"name": "Quels traitements les agences recommandent-elles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles recommandent des traitements basés sur des preuves et des protocoles établis."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils évalués ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont évalués par des essais cliniques et des revues systématiques."
}
},
{
"@type": "Question",
"name": "Les agences soutiennent-elles la recherche sur les traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles financent et soutiennent la recherche pour de nouveaux traitements."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils distribués ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont distribués par des systèmes de santé locaux et des partenariats internationaux."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon les pays ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent varier en fonction des ressources et des réglementations."
}
},
{
"@type": "Question",
"name": "Quelles complications sont surveillées par les agences ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les effets secondaires des traitements et les rechutes."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles signalées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont signalées par des systèmes de pharmacovigilance et des rapports cliniques."
}
},
{
"@type": "Question",
"name": "Les agences fournissent-elles des lignes directrices sur les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles publient des lignes directrices pour la gestion des complications."
}
},
{
"@type": "Question",
"name": "Comment les complications influencent-elles les traitements ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent nécessiter des ajustements de traitement ou des soins supplémentaires."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon les populations ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier en fonction de l'âge, du sexe et des comorbidités."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont identifiés par les agences ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le mode de vie, et les antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Comment les agences évaluent-elles les facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles utilisent des études épidémiologiques et des analyses de données."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque sont-ils différents selon les maladies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque maladie a des facteurs de risque spécifiques qui lui sont associés."
}
},
{
"@type": "Question",
"name": "Comment les agences communiquent-elles sur les facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles publient des rapports et des recommandations pour sensibiliser le public."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque peuvent-ils être modifiés ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux facteurs de risque peuvent être modifiés par des changements de mode de vie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/03/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Division of Human Health (NAHU), International Atomic Energy Agency (IAEA) Vienna, Austria.
Publications dans "Agences internationales" :
3 publications dans cette catégorie
Affiliations :
Division of Human Health, International Atomic Energy Agency, Vienna, Austria.
Publications dans "Agences internationales" :
3 publications dans cette catégorie
Affiliations :
Department of Psychology, Rikkyo University, 1-2-26 Kitano, Niiza, Saitama 352-8558, Japan; Department of Precision Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan. Electronic address: wen@rikkyo.ac.jp.
Publications dans "Agences internationales" :
2 publications dans cette catégorie
Affiliations :
Dosimetry and Medical Radiation Physics Section, International Atomic Energy Agency, Vienna, Austria.
Publications dans "Agences internationales" :
2 publications dans cette catégorie
Affiliations :
Chair for Science, Technology and Gender Studies, Friedrich-Alexander University Erlangen-Nuremberg, Bismarckstrasse 6, Erlangen 91054, Germany. Electronic address: maria.rentetzi@fau.de.
Publications dans "Agences internationales" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroscience, Christensen Lab - Cognitive Motor Neuroscience, University of Copenhagen, Panum Institute, Blegdamsvej 3B, DK - 2200, Copenhagen N, 33.3.52, Denmark.
Publications dans "Agences internationales" :
2 publications dans cette catégorie
Affiliations :
Department of Political and Social Sciences, University of Florence, Firenze, Italy.
Publications dans "Agences internationales" :
2 publications dans cette catégorie
Affiliations :
University of Washington.
Publications dans "Agences internationales" :
2 publications dans cette catégorie
Affiliations :
University of Washington.
Oregon Health and Science University.
Publications dans "Agences internationales" :
2 publications dans cette catégorie
Affiliations :
University of Washington.
Publications dans "Agences internationales" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, University of Tokyo, Tokyo, Japan; Department of Cognitive Neuroscience, ATR Cognitive Mechanisms Laboratories, Kyoto, Japan.
Publications dans "Agences internationales" :
1 publication dans cette catégorie
Affiliations :
College of Humanities, University of Exeter.
Publications dans "Agences internationales" :
1 publication dans cette catégorie
Affiliations :
School of Health Sciences, Dalhousie University, Halifax, Canada. Electronic address: catherine.gunn@dal.ca.
Publications dans "Agences internationales" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Sciences, Central University of Technology, Free State, Bloemfontein, South Africa.
Publications dans "Agences internationales" :
1 publication dans cette catégorie
Affiliations :
Oslo Metropolitan University (OsloMet), Faculty of Health Sciences, Oslo, Norway; Division of Cancer Medicine, Surgery and Transplantation, Department of Cancer Treatment, Oslo University Hospital, Oslo, Norway. Electronic address: safora.johansen@oslomet.no.
Publications dans "Agences internationales" :
1 publication dans cette catégorie
Affiliations :
Department of Education, University of Oxford, 15 Norham Gardens, Oxford, OX2 6PY UK.
Publications dans "Agences internationales" :
1 publication dans cette catégorie
Affiliations :
Department of Education, University of Oxford, 15 Norham Gardens, Oxford, OX2 6PY UK.
Publications dans "Agences internationales" :
1 publication dans cette catégorie
Affiliations :
School of Graduate Studies, Lingnan University, 8 Castle Peak Road, B.Y. Lam Building, LBY112, Lingnan, Tuen Mun, Hong Kong, People's Republic of China.
Publications dans "Agences internationales" :
1 publication dans cette catégorie
Affiliations :
Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria. Electronic address: I.veljkovik@iaea.org.
Publications dans "Agences internationales" :
1 publication dans cette catégorie
Affiliations :
World Health Organization, Geneva, Switzerland.
Publications dans "Agences internationales" :
An analysis is presented of the work of three international entities in Brazilian favelas in the 1960s: Brasil-Estados Unidos Movimento, Desenvolvimento e Organização de Comunidade; Ação Comunitária d...
In Italy, the National Register on Occupational Exposure to Carcinogens (SIREP) is established pursuant to article 243 of Legislative Decree 81/2008 and is aimed to collect information on the exposure...
To build on the success of wastewater surveillance during the COVID-19 pandemic, jurisdictions funded under the Centers for Disease Control and Prevention National Wastewater Surveillance System are l...
In July 2023, HHD met with subject matter experts (eg, bureau chiefs, program managers) in internal departments, including epidemiology, immunization, and health education, to discuss the general outl...
The internal framework established a flow for notifications and the actions to be taken by departments in HHD, with the goals of (1) ensuring timely and efficient responses to pathogen detections, (2)...
As more public health agencies expand their wastewater surveillance programs to target additional pathogens, development of internal action plans tailored to departmental capacity and programs is an i...
Dose management systems (DMS) have been introduced in radiological services to facilitate patient radiation dose management and optimization in medical imaging. The purpose of this study was to gather...
A technical survey was carried out and all DMS developers currently available (both commercial and open source) were contacted and were asked to participate. An extensive questionnaire was prepared an...
Given the way that the questions were posed, every positive response indicated that a feature was offered. Thus, the percentage of positive responses was used as a measure of adherence. The percentage...
The results of this survey clearly exhibit that large differences exist between the various DMS developers. Consequently, potential end users of a DMS should carefully determine which of the features ...
The Health Technology Assessment (HTA) Working Group of the Emerging Technology Division of International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) aims to develop a methodologic...
The objective of our IAEA-coordinated international study was to assess CT practices and radiation doses from multiple hospitals across several African countries....
The study included 13 hospitals from Africa which contributed information on minimum of 20 consecutive patients who underwent head, chest, and/or abdomen-pelvis CT. Prior to the data recording step, a...
A total of 1061 patients (mean age 50 ± 19 years) were included in the study. 16 % of CT exams had no stated clinical indications for CT examinations of the head (32/343, 9 %), chest (50/281, 18 %), a...
Concerning variations in CT practices and protocols across several hospitals in Africa were demonstrated, emphasizing the need for better protocol optimization to improve patient safety....
Implementation of radiopharmaceutical therapy dosimetry varies depending on the clinical application, dosimetry protocol, software, and ultimately the operator. Assessing clinical dosimetry accuracy a...
The sense of agency refers to the experience of control over voluntary actions and their effects. There is growing interest in the notion of we-agency, whereby individual sense of agency is supplanted...
The Partner Agencies of the International Space Station (ISS) maintain separate career exposure limits and shared Flight Rules that control the ionising radiation exposures that crewmembers can experi...
The benefits of biomedical research involving humans are well recognised, along with the need for conformity to international standards of science and ethics. When human research involves radiation im...